Meeting Overview - The shareholders' meeting of Xi'an Kanghui Pharmaceutical Co., Ltd. was held on September 4, 2025, at the company's conference room in Xi'an [1] - The meeting was conducted in accordance with the Company Law and the Articles of Association, combining on-site and online voting methods [1] Attendance and Voting Results - The meeting had a high attendance rate, with A-share shareholders voting overwhelmingly in favor of the proposals, achieving over 99.6% approval for multiple resolutions [1][2] - Specific voting results included: - 44,588,937 votes in favor (99.6210%), 24,500 against (0.0547%), and 145,100 abstentions (0.3243%) for the first resolution [1] - 44,590,237 votes in favor (99.6239%), 2,200 against (0.0049%), and 166,100 abstentions (0.3712%) for the second resolution [2] Resolutions Passed - All non-cumulative voting resolutions were approved, including the election of several directors to the sixth board of directors [3] - The resolutions included the election of Li Hongming, Wang Xiuying, Ma Wenjun, Wang Yanling, Yang Jin, Cui Xuegang, Chen Ying, and Dou Jianwei as directors [3] Legal Compliance - The meeting's procedures were verified by legal counsel, confirming compliance with relevant laws and regulations, ensuring the legitimacy of the meeting and the validity of the voting results [3]
康惠制药: 康惠制药2025年第二次临时股东大会决议公告